You are viewing: Mexico Vascular Stent Market analysis
Part of: Vascular Stent Market (Global)

The Mexico Vascular Stent Market was valued at $155.2 Million in 2024 and projected to reach to $207.3 Million by 2029, representing a compound annual growth rate of 6.0%. Mexico's vascular stent market is positioned for steady expansion through 2029, supported by improving healthcare accessibility and growing awareness of cardiovascular disease management.

Mexico Vascular Stent Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Vascular Stent Market Trends and Insights

  • This steady expansion reflects Mexico's growing healthcare infrastructure investments and rising prevalence of cardiovascular diseases across the nation.
  • Mexico's market growth is driven by increasing adoption of minimally invasive procedures, improved reimbursement policies, and expanding access to advanced medical devices in both urban and emerging healthcare centers. The vascular stent sector in Mexico benefits from demographic shifts toward an aging population and lifestyle-related risk factors that elevate demand for interventional cardiology solutions.
  • Mexico's healthcare system continues to modernize, with both public and private institutions investing in state-of-the-art catheterization laboratories and interventional capabilities.
  • Over the forecast period through 2029, Mexico is expected to see accelerated penetration of drug-eluting stents and bioresorbable stent technologies, supported by growing physician training and patient awareness initiatives throughout the country..

Key Market Statistics

  • CAGR (2024-2029) 6.0% CAGR
  • Market Size, 2024 ~USD 155.2 Million
  • Forecast, 2029 ~USD 207.3 Million
  • Country Mexico

Mexico Vascular Stent Market Overview

Market Valuation :

Mexico's vascular stent market is valued at USD 155.2 million in 2024, with projected growth to USD 207.3 million by 2029, demonstrating strong market potential in Latin America's second-largest economy.

Steady Growth Trajectory :

The Mexican market is expanding at a CAGR of 6.0%, slightly below the global average of 6.5%, reflecting localized healthcare dynamics and economic conditions specific to the country.

Healthcare Infrastructure Development :

Mexico's growing investments in healthcare infrastructure and modernization of medical facilities are driving increased adoption of advanced vascular stent technologies across public and private sectors.

Cardiovascular Disease Burden :

Rising prevalence of cardiovascular diseases in Mexico, driven by lifestyle changes and aging demographics, is creating sustained demand for vascular intervention procedures and stent solutions.

Mexico Vascular Stent Market Dynamics

  • The country's healthcare sector is increasingly adopting advanced medical technologies, with both public institutions and private hospitals investing in interventional cardiology capabilities.
  • This infrastructure development, combined with Mexico's large population and rising middle class, creates favorable conditions for market growth. The market will likely benefit from increased patient screening programs, enhanced reimbursement policies, and partnerships between international medical device manufacturers and local healthcare providers.
  • However, growth may be moderated by economic constraints and competition from lower-cost alternatives.
  • Strategic localization of products and pricing strategies will be critical for manufacturers seeking to capture market share in Mexico's evolving vascular stent landscape..

Related Ecosystem

Key Takeaways

  • Mexico's vascular stent market reaches USD 155.2 million in 2024 and will grow to USD 207.3 million by 2029 at a 6.0% CAGR.
  • Mexico's aging population and rising cardiovascular disease prevalence are primary drivers of sustained market expansion.
  • Mexico's healthcare modernization and increased catheterization lab capacity support adoption of advanced stent technologies.
  • Mexico's market is transitioning toward premium offerings including drug-eluting and bioresorbable stents through 2029.

Vascular Stent Market Report Scope

Report Metric Details
Base Year 2024
Fastest Growing Segment POLYMERIC MATERIALS (Material)
Forecast Period 2024-2029
Growth Rate CAGR of 6.5% from 2024 to 2029
Largest Segment METALLIC MATERIALS (Material)
Market Size Base Year (Billions) ~USD 11.39 (2024)
Revenue Forecast (Billions) ~USD 15.6 (2029)
Segments Covered Technology, Product, Type, Mode Of Delivery, Material, End User

Mexico Vascular Stent Market Report Segmentation

6 segment dimensions are covered across the global market.

By Technology

  • Bare Metal Stents
  • Bioabsorbable Stents
  • Covered Stents
  • Drug-Eluting Stents

By Product

  • Coronary Stents
  • Evar Stent Grafts
  • Peripheral Stents

By Type

  • Abdominal Aortic Aneurysm Stent Grafts
  • Biodegradable Polymers
  • Carotid Artery Stents
  • Cobalt Chromium
  • Femoral Artery Stents
  • Iliac Artery Stents
  • Nickel Titanium
  • Non-Biodegradable Polymers
  • Other Peripheral Stents
  • Platinum Chromium
  • Renal Artery Stents
  • Stainless Steel
  • Thoracic Aortic Aneurysm Stents Grafts

By Mode Of Delivery

  • Balloon-Expandable Stents
  • Self-Expanding Stents

By Material

  • Metallic Materials
  • Polymeric Materials

By End User

  • Cardiac Centers
  • Cardiac Centres
  • Hospitals

MEXICO: VASCULAR STENTS MARKET, BY END USER, 2024–2029

Segment202420252026202720282029CAGR (%)
CARDIAC CENTERS94.299.4104.8110.7117123.95.6
HOSPITALS132.1139.7147.6156.3165.7175.95.9
TOTAL226.3239252.4267282.7299.95.8

Target Audience

  • Medical Device Manufacturers : Vascular stent manufacturers need Mexico-specific market data to develop localized product strategies, identify distribution partnerships, and allocate resources for market expansion in this growing Latin American market.
  • Healthcare Investors : Investment firms and private equity groups require detailed Mexico market analysis to evaluate investment opportunities in cardiovascular device companies and healthcare infrastructure projects with growth potential.
  • Hospital & Clinic Administrators : Healthcare facility leaders need market insights to make informed procurement decisions, budget planning, and technology adoption strategies aligned with Mexico's cardiovascular disease management trends.
  • Market Consultants & Analysts : Business consultants and research analysts require comprehensive Mexico market data to support client advisory services, competitive analysis, and strategic planning recommendations in the medical device sector.
  • Regulatory & Government Bodies : Mexican healthcare regulators and government agencies need market intelligence to inform policy decisions, healthcare infrastructure planning, and reimbursement strategies for cardiovascular interventions.

Reasons to Buy this Report

  • Market Entry Strategy : Gain comprehensive insights into Mexico's vascular stent market dynamics to develop targeted market entry strategies and identify optimal distribution channels for your products.
  • Competitive Positioning : Understand local competitive landscape, key players, and market gaps specific to Mexico to position your offerings effectively against regional and international competitors.
  • Growth Opportunity Assessment : Evaluate the USD 52.1 million growth opportunity between 2024-2029 and identify high-potential segments within Mexico's cardiovascular device market for investment prioritization.
  • Regulatory & Reimbursement Insights : Access Mexico-specific regulatory requirements, reimbursement frameworks, and healthcare policy information essential for product approval and market commercialization planning.
  • Demand Forecasting : Utilize detailed Mexico market projections and CAGR data to forecast demand, optimize inventory management, and align production capacity with anticipated market growth through 2029.

Frequently asked questions

What is the current size of Mexico's vascular stent market?

Mexico's vascular stent market is valued at USD 155.2 million in 2024.

What is the projected market size for Mexico's vascular stent sector by 2029?

Mexico's vascular stent market is forecast to reach USD 207.3 million by 2029.

What is the growth rate (CAGR) for Mexico's vascular stent market?

Mexico's vascular stent market is expected to grow at a compound annual growth rate of 6.0% from 2024 to 2029.

What factors are driving growth in Mexico's vascular stent market?

Key drivers in Mexico include an aging population, rising cardiovascular disease prevalence, healthcare infrastructure modernization, improved reimbursement policies, and expanding access to minimally invasive interventional procedures.

Which stent types are gaining traction in Mexico's market?

Mexico's market is increasingly adopting drug-eluting stents and bioresorbable stent technologies, supported by physician training and patient awareness initiatives.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the vascular stent market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of Vascular stent Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after obtaining information regarding the vascular stent market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific,  Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Vascular stent market.; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Vascular Stents Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue.

As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=<USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the vascular stent market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the Vascular stent market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall vascular stent market was obtained from secondary data and validated by primary participants to arrive at the total vascular stent market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Vascular stent market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Vascular stent Market Size: Top-Down Approach

Vascular Stents Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Vascular stent Market Size: Bottom-Up Approach

Vascular Stents Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Vascular stent industry.

Market Definition:

Vascular stents are metallic or polymeric meshes designed to apply uniform radial force within blood vessels, ensuring they remain open and function properly. These stents are implanted in the vascular system to maintain blood flow to the heart muscle.

Key Stakeholders

  • Vascular Stent Manufacturers
  • Various Research and Consulting Companies
  • Healthcare Institutions (Hospitals, Cardiac Centers, and Surgical Centers)
  • Vascular Stent Distributors and Suppliers
  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical and medical device companies

Report Objectives

  • To define, describe, and forecast the vascular stent market based on technology, product, mode of delivery, material, end user, and region.
  • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events.
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall vascular stent market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile key players in the vascular stent market and comprehensively analyze their core competencies.
  • To track and analyze competitive developments such as product/service launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall vascular stent market.
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy.
  • To analyze the impact of the recession on the vascular stent market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis:  Further breakdown of the Latin American Vascular stent into specific countries and, the Middle East, and Africa Vascular stent into specific countries and further breakdown of the European Vascular stent into specific countries,

Get the Full Vascular Stent Market Report

Full forecast, segment splits, and company analysis for all Vascular Stent Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status